Both in Pharmaceuticals
Nomad Power Solutions vs Citius Oncology
Over the past year NMAD returned +1.7% and CTOR returned −40.4%; their daily moves had a correlation of 0.03.
NMAD +1.7% CTOR −40.4%Growth of $1, one year, split-adjusted
| Metric | NMAD | CTOR |
|---|---|---|
| Price | $3.60 | $0.5470 |
| Market cap | $58.0M | $57.9M |
| Today | +2.27% | −0.55% |
| 1 month | −17.1% | −35.6% |
| 6 months | — | −39.8% |
| Year to date | — | −45.3% |
| 1 year | — | −67.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.1× |
| Net cash | — | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 98.9% |
| Short % of float | 11.0% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).